Drug Patent Expirations for the Week of June 2, 2024

By / June 5, 2024

ILEVRO (nepafenac)

Harrow eyePatent: 7,947,295Expiration: Jun 8, 2024

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Post navigation

Which pharmaceutical drugs have the most drug patents in Netherlands?

Which pharmaceutical drugs have the most drug patents in Poland?

New patent expiration for Arbor Pharms drug BIDIL

Patent Expiration / By

Patent delisted for Teva Pharms drug COPAXONE

Patent Expiration / By

Get Email Updates

Make Better Decisions

See Plans and Pricing

Search for:

Make Better Decisions with DrugPatentWatch

Related Posts